- Home
- CTRN vs VNDA Comparison
CTRN vs VNDA Comparison
Compare CTRN & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRN
- VNDA
- Stock Information
- Founded
- CTRN 1946
- VNDA 2002
- Country
- CTRN United States
- VNDA United States
- Employees
- CTRN N/A
- VNDA N/A
- Industry
- CTRN Clothing/Shoe/Accessory Stores
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- CTRN Consumer Discretionary
- VNDA Health Care
- Exchange
- CTRN Nasdaq
- VNDA Nasdaq
- Market Cap
- CTRN 280.0M
- VNDA 249.4M
- IPO Year
- CTRN 2005
- VNDA 2006
- Fundamental
- Price
- CTRN $32.59
- VNDA $4.75
- Analyst Decision
- CTRN Buy
- VNDA Strong Buy
- Analyst Count
- CTRN 2
- VNDA 2
- Target Price
- CTRN $24.50
- VNDA $16.50
- AVG Volume (30 Days)
- CTRN 45.3K
- VNDA 551.9K
- Earning Date
- CTRN 08-26-2025
- VNDA 07-31-2025
- Dividend Yield
- CTRN N/A
- VNDA N/A
- EPS Growth
- CTRN N/A
- VNDA N/A
- EPS
- CTRN N/A
- VNDA N/A
- Revenue
- CTRN $768,518,000.00
- VNDA $203,467,000.00
- Revenue This Year
- CTRN $6.80
- VNDA $16.86
- Revenue Next Year
- CTRN $4.61
- VNDA $39.78
- P/E Ratio
- CTRN N/A
- VNDA N/A
- Revenue Growth
- CTRN 1.85
- VNDA 11.78
- 52 Week Low
- CTRN $13.66
- VNDA $3.81
- 52 Week High
- CTRN $34.63
- VNDA $5.55
- Technical
- Relative Strength Index (RSI)
- CTRN 57.81
- VNDA 60.39
- Support Level
- CTRN $31.22
- VNDA $4.47
- Resistance Level
- CTRN $32.84
- VNDA $4.88
- Average True Range (ATR)
- CTRN 1.26
- VNDA 0.16
- MACD
- CTRN 0.09
- VNDA 0.05
- Stochastic Oscillator
- CTRN 78.26
- VNDA 82.43
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.